Multiparameter flow cytometry in the diagnosis and management of acute leukemia.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Pathology & Laboratory Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1043/2010-0387-RAR.1PMID 21204710
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute Lymphoblastic Leukemia in Children and Adolescents

  2018cited by this paper
• Monitoring of minimal residual disease in acute myeloid leukemia

  2011influential reference
• Acute lymphoblastic leukemia.

  2009cited by this paper
• Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation

  2009cited by this paper
• The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

  2009cited by this paper
• Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction

  2009cited by this paper
• Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases

  2009cited by this paper
• How and why minimal residual disease studies are necessary in leukemia: a review from WP10 and WP12 of the European LeukaemiaNet

  2009cited by this paper
• Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry.

  2009cited by this paper
• The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.

  2009cited by this paper
• Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

  2009cited by this paper
• Monitoring of minimal residual disease in acute myeloid leukemia

  2009cited by this paper
• A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B‐cell (CD20+) non‐Hodgkin lymphoma and mature B‐cell acute lymphoblastic leukemia: A report from the Children's Oncology Group

  2009cited by this paper
• HLA‐DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia

  2009influential reference
• Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.

  2009cited by this paper
• Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia.

  2009cited by this paper
• Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity

  2009cited by this paper
• Minimal residual disease quantitation in acute myeloid leukemia.

  2009cited by this paper
• Minimal residual disease detection in childhood acute lymphoblastic leukaemia patients at multiple time‐points reveals high levels of concordance between molecular and immunophenotypic approaches

  2009cited by this paper
• 10-Parameter Flow Cytometry as a New Tool to Improve Diagnosis and MRD Follow-Up of Acute Leukemias

  2009cited by this paper
• Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study

  2009cited by this paper
• T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993).

  2009cited by this paper
• Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

  2008cited by this paper
• Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.

  2008influential reference
• Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.

  2008cited by this paper
• Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

  2008cited by this paper
• Hematogones in acute leukemia during and after therapy

  2008cited by this paper
• Improving treatment strategies for acute lymphoblastic leukemia by combining immunotherapy and chemotherapy.

  2008cited by this paper
• Why and how to quantify minimal residual disease in acute lymphoblastic leukemia?

  2007cited by this paper
• CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

  2007cited by this paper
• The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.

  2007cited by this paper
• TUMORS OF HEMATOPOIETIC AND LYMPHOID TISSUES

  2007influential reference
• Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience.

  2007cited by this paper
• Use of five-color staining improves the sensitivity of multiparameter flow cytomeric assessment of minimal residual disease in patients with acute myeloid leukemia

  2007cited by this paper
• Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group

  2005cited by this paper
• Uncommon phenotypes of acute myelogenous leukemia: basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: a review.

  2005influential reference
• Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia

  2004cited by this paper
• Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping

  2004cited by this paper
• Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias.

  2004cited by this paper
• Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

  2003influential reference
• Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.

  2001cited by this paper
• Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification.

  2001influential reference
• Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).

  1997cited by this paper
• Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.

  1993cited by this paper

• RNA Sequencing Identifies WT1 Overexpression as a Predictor of Poor Outcomes in Acute Myeloid Leukemia

  2025cites this paper
• Genetic characteristics and prognosis of m6A RNA methylation regulator in acute myeloid leukemia

  2025cites this paper
• Understanding leukemia and its clinical significance

  2025cites this paper
• World Health Organization (WHO)’s vision for a leukemia-free Africa: opportunities and challenges- a narrative review

  2025cites this paper
• Immunophenotypic Profiling of Acute Promyelocytic Leukemia: Insights From a Large Cohort

  2025cites this paper
• Diagnóstico y tratamiento de la leucemia linfoblástica aguda pediátrica: reseña histórica

  2025cites this paper
• Comparison of Cytochemistry and Flow Cytometry for Leukemia Immunophenotyping: A Systematic Review and Meta-Analysis

  2025cites this paper
• Comparison Between Acute Leukemia Screening Tube and Lineage-Specific Panels for the Diagnosis of Acute Leukemia in Kenya.

  2025cites this paper
• Distinguishing Reactive Lymphocytes From Blasts Using Fractal Chromatin Patterns

  2025cites this paper
• Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review

  2025cites this paper
• The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia

  2025cites this paper
• Exploring the interplay between microRNA expression and DNA mutation analysis in AML patients

  2024cites this paper
• ClearLLab 10C reagents panel can be applied to analyze paucicellular samples by flow cytometry

  2024cites this paper
• Immunophenotypic clustering in paediatric acute myeloid leukaemia

  2024cites this paper
• Raman classification of selected subtypes of acute lymphoblastic leukemia (ALL).

  2023cites this paper
• Label-free, Rapid and Highly Accurate Identification and Categorization of Leukemia Cells via Raman Spectroscopy

  2023cites this paper
• Typing of acute leukemia by intelligent optical time-stretch imaging flow cytometry on a chip.

  2023cites this paper
• Exosomal circRNA-001264 promotes AML immunosuppression through induction of M2-like macrophages and PD-L1 overexpression.

  2023cites this paper
• The Role of Erythrocyte Sedimentation Rate (ESR) in Myeloproliferative and Lymphoproliferative Diseases: Comparison between DIESSE CUBE 30 TOUCH and Alifax Test 1

  2023cites this paper
• Immunophenotypic characterization of acute leukemias in Bahia, Brazil

  2022cites this paper
• Radioterapia en pacientes pediátricos con leucemia linfocítica aguda: experiencia de 9 años

  2022cites this paper
• Quartz Crystal Microbalance-Based Aptasensors for Medical Diagnosis

  2022cites this paper
• Monocytosis and Multiple Myeloma: treatment-related acute leukaemia?

  2022cites this paper
• A Flow-Cytometric Analysis of Spectrum of Acute Myeloid Leukemia at Diagnosis

  2021cites this paper
• A non-invasive tool for early detection of acute leukemia in children using a paper-based optoelectronic nose based on an array of metallic nanoparticles.

  2021cites this paper
• Diagnostic Utility of Immunophenotyping by Flow Cytometry for Diagnosis and Classification of Acute Leukemias in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia

  2021cites this paper
• Flow cytometric evaluation and outcomes of pediatric acute leukemia patients Çocukluk çağında akut lösemi tanısı alan hastaların sonuçları ve akım sitometri ile değerlendirilmesi

  2021cites this paper
• The Application of Single-Cell Technologies in Cardiovascular Research

  2021cites this paper
• Neoteric Algorithm Using Cell Population Data (VCS Parameters) as a Rapid Screening Tool for Haematological Disorders

  2021cites this paper
• Immunophenotypic profile and aberrancies in Acute Leukaemia: A study from tertiary oncology centre in south India

  2020cites this paper
• Essentials of the Immune Response and Immunophenotyping

  2020cites this paper
• Correlation of cyto-morphology with flow cytometric immunophenotyping in acute leukemia's-A Comparative study

  2020cites this paper
• Morphological Diagnosis and Immunophenotypic Characterization of Onco-hematologic Malignancy (Acute Myelogenous Leukemia-M3 and M4): Two Pediatric Case Reports and Literature Review

  2020influential citation
• Acute undifferentiated leukemia: data on incidence and outcomes from a large population-based database.

  2020cites this paper
• Utility of CD36 as a novel addition to the immunophenotypic signature of RAM‐phenotype acute myeloid leukemia and study of its clinicopathological characteristics

  2020cites this paper
• Bacterial mock communities as standards for reproducible cytometric microbiome analysis

  2020cites this paper
• Multiple myeloma secondary to acute lymphoblastic leukemia

  2019cites this paper
• DNA Aptamers in the Detection of Leukemia Cells by the Thickness Shear Mode Acoustics Method.

  2019cites this paper
• Clinical and Prognostic Significance of Cell Sensitivity to Chemotherapy Detected In Vitro on Treatment Response and Survival of Leukemia Patients

  2019cites this paper
• CLINICAL AND HAEMATOLOGICAL EVALUATION OF LEUKAEMIAS, USING CYTOCHEMICAL STAINS AND IMMUNOPHENOTYPING

  2019cites this paper
• Acute lymphoblastic T cell leukemia restricted to the central nervous system: Case report

  2019cites this paper
• Fluorescence spectral detection of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML): A novel photodiagnosis strategy.

  2019cites this paper
• FLT3N676K drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis

  2019cites this paper
• Marker subset selection and decision support range identification for acute myeloid leukemia classification model development with multiparameter flow cytometry

  2019cites this paper
• Raman Spectroscopy for Biomedical Applications: From Label-free Cancer Cell Sorting to Imaging

  2019influential citation
• Infection risk for chemotherapy-induced neutropenia in Hodgkin lymphoma and acute myeloid leukemia

  2019cites this paper
• Report of a new six-panel flow cytometry marker for early differential diagnosis of APL from HLA-DR negative Non-APL leukemia

  2019cites this paper
• Immunophenotypic characterisation of morphologically diagnosed cases of Acute Myeloid Leukaemia (AML)

  2019cites this paper
• Morphologic and immunophenotypic features of a case of acute monoblastic leukemia with unusual positivity for Glycophorin-A

  2018cites this paper
• Acute monocytic leukemia diagnosed by flow cytometry includes acute myeloid leukemias with weakly or faintly positive non-specific esterase staining

  2018cites this paper
• Raman detection and identification of normal and leukemic hematopoietic cells

  2018cites this paper
• SPECTRUM OF ACUTE LEUKEMIAS AND ABERRANT MARKERS EXPRESSION BASED ON FLOWCYTOMETRY IN A TERTIARY CARE CENTRE

  2018cites this paper
• [INVITED] Raman microscopy based sensing of leukemia cells: A review

  2018cites this paper
• Acute myeloid leukaemia.

  2018cites this paper
• Preliminary investigation on the abnormal mechanism of CD4+FOXP3+CD25high regulatory T cells in pediatric B-cell acute lymphoblastic leukemia.

  2018cites this paper
• A simple fluorescence biosensing strategy for ultrasensitive detection of the BCR-ABL1 fusion gene based on a DNA machine and multiple primer-like rolling circle amplification.

  2018cites this paper
• Integrated automated particle tracking microfluidic enables high‐throughput cell deformability cytometry for red cell disorders

  2018cites this paper
• Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.

  2018cites this paper
• Application of Molecular Karyotyping in Acute Myeloid Leukemia: A Review

  2018cites this paper
• A Method for the Interpretation of Flow Cytometry Data Using Genetic Algorithms

  2018cites this paper
• Mixed Phenotype Acute Leukemia, B/Myeloid with t(9;22): Diagnostic and Therapeutic Challenges

  2018cites this paper
• Label‐free Electrochemical Aptasensor for Jurkat Cells Detection as a Potential Diagnostic Tool for Leukemia

  2018cites this paper
• Integration of glass micropipettes with a 3D printed aligner for microfluidic flow cytometer

  2018cites this paper
• Identification of MS4A3 as a reliable marker for early myeloid differentiation in human hematopoiesis.

  2018cites this paper
• Current status and trends in the diagnostics of AML and MDS.

  2018cites this paper
• Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.

  2017cites this paper
• Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients

  2017cites this paper
• Role of new Immunophenotypic Markers on Prognostic and Overall Survival of Acute Myeloid Leukemia: a Systematic Review and Meta-Analysis

  2017cites this paper
• Automated Assessment of Disease Progression in Acute Myeloid Leukemia by Probabilistic Analysis of Flow Cytometry Data

  2017cites this paper
• Laser flow cytometry as a tool for the advancement of clinical medicine.

  2017cites this paper
• CD3D and PRKCQ work together to discriminate between B-cell and T-cell acute lymphoblastic leukemia

  2016cites this paper
• ADDIS ABABA UNIVERSITY COLLEGE OF HEALTH SCIENCES SCHOOL OF ALLIED HEALTH SCIENCES DEPARTMENT OF MEDICAL LABORATORY SCIENCES DIAGNOSTIC UTILITY OF IMMUNOPHENOTYPING BY FLOW CYTOMETRY FOR DIAGNOSIS AND CLASSIFICATION OF ACUTE LEUKEMIAS IN TIKUR ANBESSA SPECIALIZED HOSPITAL, ADDIS ABABA, ETHIOPIA

  2016cites this paper
• Cellometer image cytometry as a complementary tool to flow cytometry for verifying gated cell populations.

  2016cites this paper
• Increasing the Efficacy of Detecting Residual Cancer Cells Using a Whole-Slide Image Scanning Method and a Computer-Aided Detection Scheme

  2016cites this paper
• Impact of Aberrant Antigens in the Outcome of Patients with Acute Leukemia at a Referral Institution in Mexico City.

  2016cites this paper
• Microfluidic cell surface antigen expression analysis using a single antibody type.

  2016cites this paper
• flowVS: channel-specific variance stabilization in flow cytometry

  2016cites this paper
• Current Strategies for the Detection of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia

  2016cites this paper
• A reliable Raman-spectroscopy-based approach for diagnosis, classification and follow-up of B-cell acute lymphoblastic leukemia

  2016cites this paper
• Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia

  2016cites this paper
• Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used

  2016cites this paper
• A Leukemia-Associated CD 34 / CD 123 / CD 25 / CD 99 þ Immunophenotype Identi fi es FLT 3-Mutated Clones in Acute Myeloid Leukemia

  2015cites this paper
• Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.

  2015cites this paper
• Developing a process control strategy for the consistent and scalable manufacture of human mesenchymal stem cells

  2015cites this paper
• Two-nozzle hydrodynamic focusing

  2015cites this paper
• Use of Flow Cytometry Immunophenotyping for Diagnosis of Acute Leukemia at Moi Teaching and Referral Hospital, Eldoret, Kenya

  2015cites this paper
• A Leukemia-Associated CD34/CD123/CD25/CD99-positive Immunophenotype Identifies FLT3 -mutated Clones in Acute Myeloid Leukemia

  2015cites this paper
• An Algorithmic Pipeline for Analyzing Multi-parametric Flow Cytometry Data

  2015cites this paper
• Flow Cytometry II: Mass and Imaging Cytometry.

  2015cites this paper
• A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3-Mutated Clones in Acute Myeloid Leukemia

  2015cites this paper
• ImmuSort, a database on gene plasticity and electronic sorting for immune cells

  2015cites this paper
• 1 Multiparameter flow cytometry for the characterisation of extracellular markers 2 on human mesenchymal stem cells 3

  2014cites this paper
• Normal-Karyotype Acute Myeloid Leukemia

  2014cites this paper
• UNIVERSIDADE FEDERAL DE SERGIPE CENTRO DE CIÊNCIAS BIOLÓGICAS E DA SAÚDE DEPARTAMENTO DE FARMÁCIA

  2014cites this paper
• Recent advancements of flow cytometry: new applications in hematology and oncology

  2014cites this paper
• An aptamer-based quartz crystal microbalance biosensor for sensitive and selective detection of leukemia cells using silver-enhanced gold nanoparticle label.

  2014cites this paper
• Node-Pore Sensing: A Robust, High Dynamic Range Method for Multi-Parametric Screening of Biological Samples

  2014cites this paper
• Diagnostic immunophenotype of acute promyelocytic leukemia before and early during therapy with all-trans retinoic acid.

  2014cites this paper
• [Aberrant immunophenotypes in acute leukemia in a Buenos Aires' hospital population].

  2013cites this paper
• Inmunofenotipos aberrantes en leucemias agudas en una población hospitalaria de Buenos Aires

  2013cites this paper